NCT06376916View on ClinicalTrials.gov

Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR

PHASE3RecruitingINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

October 7, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Tachycardia AtrialAtrial FibrillationAtrial Flutter With Rapid Ventricular Response
Interventions
DRUG

Magnesium Sulfate 2 G

Magnesium Sulfate 2g for the treatment of atrial fibrillation or atrial flutter with rapid ventricular response (AFF RVR)

DRUG

Magnesium Sulfate 4 G

Magnesium Sulfate 4g for the treatment of atrial fibrillation or atrial flutter with rapid ventricular response (AFF RVR)

DRUG

Saline

The control group will receive a bolus of normal saline of the same volume and infused over 15 minutes.

Trial Locations (1)

60453

RECRUITING

Advocate Christ Medical Center Emergency Department (ACMC ED), Oak Lawn

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER